Dr Rachel Dear is a medical oncologist at St Vincent’s Hospital in Darlinghurst, Sydney. She sees patients at the Kinghorn Cancer Centre and has admitting rights at both St Vincent’s Hospital and St Vincent’s Private Hospital. She is also a Conjoint Lecturer at the University of New South Wales and a Senior Lecturer in the Sydney Medical School at the University of Sydney.
Rachel was awarded her medical degree with first class honours from the University of New South Wales in 2001 and undertook junior medical officer and basic physician’s training at St Vincent’s Hospital, Darlinghurst which she completed in 2005. This was followed by advanced medical oncology training at Westmead Hospital. She became a Fellow of the Royal Australasian College of Physicians in 2008. In 2012 Rachel was awarded a PhD titled “The potential of clinical trial registries to inform cancer care in Australia” from the Sydney Medical School at the University of Sydney. A major focus of her PhD is optimizing doctor-patient communication. During her PhD she held a NSW Cancer Institute Research Scholar Award from 2009-2012. From 2012 to 2013 she worked at the Mater Hospital in North Sydney before starting her current role as a Staff Specialist at St Vincent’s Hospital in 2014.
Rachel’s main interests are breast, lung and brain cancers. She has completed a Cochrane Systematic Review titled “Combination versus sequential single agent chemotherapy for metastatic breast cancer”. She was an invited speaker at the Advanced Breast Cancer Second International Consensus Conference in Portugal in November 2013 to present the results of the Cochrane Review.
Rachel is a member of the Medical Oncology Group of Australia, the Clinical Oncology Society of Australia, the Australian and New Zealand Breast Cancer Trials Group, the Australasian Lung Cancer Trials Group, the Cooperative Trials Group for neuro-oncology, and the American Society of Clinical Oncology. Rachel is the lead investigator for a number of local and international research studies and is involved in the development and conduct of clinical trials.